Sort by
Refine Your Search
-
of theranostic radioligands targeting tumor-associated proteases. Project overview: The Radiopharmacy group has extensive expertise in the development of radiolabeled ligands for proteases implicated in human
-
research activities within the Radiopharmacy (CREANT) department and the Molecular Imaging Center Antwerp (MICA), focusing on the preclinical evaluation of theranostic radioligands targeting tumor
-
economic sociology, the sociology of imagined futures or related fields of research is considered an asset. You have a proven track record of publishing in international, peer-reviewed journals. You are
-
considered an asset. You have a proven track record of publishing in international, peer-reviewed journals. You are reliable, capable of working independently, and demonstrate initiative. You possess strong
-
we have added to our pages. If you do not allow these cookies, some or all of the services may not work properly. Targeted cookies They can be set up by our advertising partners on our site to build a